Amyloid Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Amyloid stocks.

Amyloid Stocks Recent News

Date Stock Title
May 15 IONS Ionis to host 2024 virtual Annual Meeting of Stockholders
May 15 LLY These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now
May 14 LLY Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
May 14 LLY Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
May 14 ABOS Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript
May 14 LLY Lilly target price raised at Argus on Mounjaro, Zepbound sales
May 14 GMAB Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
May 14 LLY 2 Top Pharma Stocks That Just Keep Getting Better and Better
May 14 NTLA Intellia Therapeutics, Inc. (NTLA) Just Overtook the 50-Day Moving Average
May 14 BBIO BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024
May 14 LLY Is Eli Lilly's Latest Deal a Gamechanger?
May 14 ABOS Acumen Pharmaceuticals GAAP EPS of -$0.25
May 14 ABOS Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
May 14 PRTA News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts
May 14 LLY 3 Magnificent Stocks That Are Passive Income Machines
May 14 GMAB Danish biotech says companies should tap into China’s ‘impressive innovation’
May 13 LLY Wegovy weight loss sustained for four years in trial, Novo Nordisk says
May 13 LLY Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
May 13 ABOS Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13 ANVS Annovis Bio GAAP EPS of -$0.10 beats by $0.53
Amyloid

Amyloids are aggregates of proteins characterised by a fibrillar morphology of 7–13 nm in diameter, a β-sheet secondary structure (known as cross-β) and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits in plaques around cells which can disrupt the healthy function of tissues and organs.
Such amyloids have been associated with (but not necessarily as the cause of) more than 50 human diseases, known as amyloidosis, and may play a role in some neurodegenerative disorders. Some of these diseases are mainly sporadic and only a few cases are familial. Others are only familial. Some are iatrogenic as they result from medical treatment. One amyloid protein is infectious and is called prion in which the infectious form can act as a template to convert other non-infectious proteins into infectious form. Amyloids may also have normal biological functions; for example, in the formation of fimbriae in some genera of bacteria, transmission of epigenetic traits in fungi, as well as pigment deposition and hormone release in humans.Amyloids have been known to arise from many different proteins. These polypeptide chains generally form β-sheet structures that aggregate into long fibers; however, identical polypeptides can fold into multiple distinct amyloid conformations. The diversity of the conformations may have led to different forms of the prion diseases.

Browse All Tags